Singular Genomics Appoints John Stark as CEO

April 30, 2026
Singular Genomics Systems has appointed John Stark as Chief Executive Officer as the company expands its spatial genomics platform and focuses on broader adoption in translational research and clinical applications.

Singular Genomics has appointed John Stark as Chief Executive Officer, announced in a press release. The leadership change comes as the company advances its spatial genomics platform and seeks to expand adoption across research and clinical markets.

Stark succeeds Josh Stahl, who will transition to the role of Independent Director on the Board. The company stated that with its G4X Spatial Sequencer now commercially available, the focus will shift to scaling operations and strengthening strategic partnerships.

John Stark brings more than 25 years of experience in commercializing life science technologies. He previously served as CEO of Resolve Biosciences, Quantum-Si, and Celsee, and held senior roles at Life Technologies, Pacific Biosciences, and Affymetrix.

Based in San Diego, Singular Genomics develops high throughput spatial pathology solutions for translational research, drug development, and precision medicine.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Enterprise AI Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Enterprise

04/30
Trust3 AI and Dell Partner on Secure AI Ready Data Lakehouse Infrastructure
04/30
Rad AI Names David Leonard COO and Elizabeth Bergey CCO
04/30
Carrum Health Names New Tech Leaders to Expand AI and Data Capabilities
04/30
InterProse Adds Ron Totaro and Ray Peloso to Board of Directors
04/30
Unilumin Tops LED Market for Third Year, Expands Focus on AI and Metasight Ecosystems

More from: Life Sciences

04/30
Photon Raises $16 Million Series A to Expand AI Prescription Infrastructure
04/30
Rad AI Names David Leonard COO and Elizabeth Bergey CCO
04/30
Carrum Health Names New Tech Leaders to Expand AI and Data Capabilities
04/30
Arizton Projects Europe Laboratory Information Systems Market to Reach $689 Million by 2031
04/30
Haier Biomedical Reports Record Overseas Revenue in 2025 Annual Results

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more

You May Also Like